Haleon plc (LON:HLN)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 381.50
-1.20 (-0.31%)
Oct 23, 2026, 9:53 AM BST
Haleon Financials Overview
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 11,152 | 11,030 | 11,233 | 11,302 | 10,858 | 9,545 |
Revenue Growth | 1.11% | -1.81% | -0.61% | 4.09% | 13.76% | -3.51% |
Gross Profit Gross Profit Growth | 7,312 | 7,144 | 7,103 | 6,962 | 6,729 | 5,984 |
Operating Income Operating Income Growth | 2,618 | 2,503 | 2,487 | 2,483 | 2,396 | 1,943 |
Net Income Net Income Growth | 1,623 | 1,667 | 1,442 | 1,049 | 1,060 | 1,390 |
Earnings Per Share EPS Growth | 0.18 | 0.18 | 0.16 | 0.11 | 0.11 | 0.15 |
EPS Growth | -2.12% | 17.83% | 38.94% | -1.55% | -23.75% | 21.40% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Oral Health Oral Health Growth | 3,571 | 3,461 | 3,312 | 3,136 | 2,957 | 2,724 |
Vitamins, Minerals and Supplement Vitamins, Minerals and Supplement Growth | 1,701 | 1,685 | 1,696 | 1,640 | 1,675 | 1,501 |
Pain Relief Pain Relief Growth | 2,601 | 2,564 | 2,564 | 2,652 | 2,551 | 2,237 |
Respiratory Health Respiratory Health Growth | 1,830 | 1,873 | 2,122 | - | - | - |
Digestive Health Digestive Health Growth | 986 | 987 | 1,029 | - | - | - |
Therapeutic Skin Health and Other Therapeutic Skin Health and Other Growth | 463 | 460 | 510 | - | - | - |
Revenue (Total) Revenue (Total) Growth | 11,152 | 11,030 | 11,233 | 11,302 | 10,858 | 9,545 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 826 | 1,350 | 2,328 | 1,049 | 684 | 414 |
Total Debt Total Debt Growth | 8,252 | 8,633 | 10,244 | 9,606 | 10,646 | 1,010 |
Net Cash (Debt) Net Cash Growth | -7,426 | -7,283 | -7,916 | -8,557 | -9,962 | -596 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.83 | -0.81 | -0.86 | -0.92 | -1.08 | -0.06 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 2,651 | 2,634 | 2,301 | 2,100 | 2,063 | 1,356 |
Capital Expenditures CapEx Growth | -336 | -322 | -250 | -234 | -304 | -228 |
Free Cash Flow Free Cash Flow Growth | 2,315 | 2,312 | 2,051 | 1,866 | 1,759 | 1,128 |
Free Cash Flow Growth | 0.13% | 12.72% | 9.91% | 6.08% | 55.94% | -4.81% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 65.57% | 64.77% | 63.23% | 61.60% | 61.97% | 62.69% |
Operating Margin | 23.48% | 22.69% | 22.14% | 21.97% | 22.07% | 20.36% |
Pretax Margin | 19.13% | 19.51% | 17.00% | 14.40% | 14.90% | 17.14% |
Profit Margin | 14.55% | 15.11% | 12.84% | 9.28% | 9.76% | 14.56% |
FCF Margin | 20.76% | 20.96% | 18.26% | 16.51% | 16.20% | 11.82% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.073 | 0.071 | 0.066 | 0.060 | 0.024 |
Dividend Per Share Growth | 7.35% | 7.58% | 10.00% | 150.00% | - |
Dividend Yield | 1.91% | 1.89% | 1.75% | 1.86% | 0.73% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 21.07 | 20.02 | 23.69 | 28.32 | 28.52 | - |
Forward PE | 17.41 | 18.86 | 20.12 | 17.20 | 16.91 | - |
P/FCF Ratio | 14.56 | 14.44 | 16.66 | 15.92 | 17.19 | - |
PS Ratio | 3.02 | 3.03 | 3.04 | 2.63 | 2.78 | - |